GARD Steering committee report J Bousquet, R Dahl

GARD

Steering committee report

J Bousquet, R Dahl

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

3- Modified TOR

4- Preparation of the Launch

5- "GARD manual"

6- Dissemination of GARD to countries

GARD Stepwise approachMay 2005

GARD priorities

Integrated GARD action plan

Step 1Step 2

Step 3

2005 2006 2007 2008 2009 2010

Pilot studies in countries

GARD action plan in countries

GARD priorities

Integrated GARD action plan

Step 1Step 2

Step 3

2005 2006 2007 2008 2009 2010

Pilot studies in countries

GARD action plan in countries

GARD Stepwise approachMarch 2006

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

October 5, 2005

QuickTime™ et undécompresseur TIFF (LZW)

sont requis pour visionner cette image.

Estimate population needs and advocate

WG.1- Burden, risk factors and surveillance (G

Viegi, S Buist, Y Fukuchi)

WG.2- Awareness and advocacy (C Lenfant, A

Turnbull, P van Cauwenberge)

Formulate and adopt policy

WG.3- Prevention and health promotion (M Boland, A

Custovic)

WG.4- Diagnosis of CRD (K Rabe, S Wenzel)

WG.5- Control of CRD and allergies,

Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel)

WG.6- Pediatric asthma (C Baena-Cagnani, E

Mantzouranis, FER Simons, E Valovirta)

Formulate and adopt policy

WG.3- Prevention and health promotion (M Boland, A

Custovic)

WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy

(GW Canonica)

WG.5- Control of CRD and allergies,

Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel)

WG.6- Pediatric asthma (C Baena-Cagnani, E

Mantzouranis, FER Simons, E Valovirta)

Formulate and adopt policy

WG.3- Prevention and health promotion (M Boland, A

Custovic)

WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy

(GW Canonica)

WG.5- Control of CRD and allergies (J Bousquet, E

Bateman, L Fabbri, C van Weel)

Availability and affordability of drugs (N Aït Khaled)

WG.6- Pediatric asthma (C Baena-Cagnani, E

Mantzouranis, FER Simons, E Valovirta)

In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients

In upper-middle income countries- few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places

In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places

In all countries, health promotion and prevention are essential

control by disease-specific approach control by syndromic approach no control

Current management of CRDCurrent management of CRD

In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients

In upper-middle income countries- few patients can receive adequate diagnosis and treatment - the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places

In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment- the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places

In all countries, health promotion and prevention are essential

control by disease-specific approach control by syndromic approach no control

GARD policyGARD policy

Identify Policy Implementation Steps

National Coordination:

• The GARD action plan should be applied at the country level

• Establish national working groups with a national coordinator

• The national coordination group will:

• Provide existing national statistics on CRD and allergies

• Assess the specific needs for the given country

• Review the GARD action plan

• Determine the relevant issues for the country action plan

• Develop a country-specific action plan

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

WHO calls for a global and coordinated effortto fight chronic respiratory diseases

WE ARE GARD!

GARD members

Governmental organizationsScientific societiesPatient's organizationsOther NGOs

Pharmaceutical industry

Governments

Year 1 Year 2

"Medical" Foundations

GARD members

Governmental organizationsScientific societiesPatient's organizationsOther NGOs

Pharmaceutical industry

Governments

Year 1 Year 2

"Medical" Foundations

Targetted approachTargetted approach

GARD members

Governmental organizationsScientific societiesPatient's organizationsOther NGOs

Pharmaceutical industry

Governments

Year 1 Year 2

World BankUnesco and others

Private sector

"Medical" Foundations

Foundations

GARD members

Governmental organizationsScientific societiesPatient's organizationsOther NGOs

Pharmaceutical industry

Governments

Year 1 Year 2

World BankUnesco and others

Private sector

"Medical" Foundations

Foundations

Targetted approach firstTargetted approach first

Global approach laterGlobal approach later

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

3- Modified TOR

GARD TOR

• TOR december 2004: approved by members

• Assembly meeting: revision of TOR NOT sent

to WHO

• to include private sector, WHO proposed a

revised TOR (TOR2) (january 2006)

• TOR2 should be discussed during the

meeting and proposal sent to WHO

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

3- Modified TOR

4- Preparation of the Launch

Fact sheet

"Hundreds of millions of people suffer from chronic

respiratory diseases worldwide, including:

o 300 million people with

asthma

o 62 million people with

moderate to severe COPD

o Millions of others with mild

COPD, allergic rhinitis, and other chronic

respiratory diseases, which are often

undiagnosed."

Chronic respiratory diseases

asthma 300 millions GINA, 2004

Moderate to severe COPD 62 millions WHO, 2006

Allergic rhinitis millions

Secondary pulmonary hypertension

Occupational CRD

Chronic rhinosinusitis

Post-infectious CRD

Lung cancer and neoplasms of the respiratory organs

Sequellae of pulmonary embolism

Cor pulmonale

Sleep apnea syndrome

Lung fibrosis

TOTAL: Hundreds of millions

Chronic respiratory diseases

asthma 300 millions GINA, 2004

COPD 150 millions

Allergic rhinitis 400 millions

Secondary pulmonary hypertension 25 millions

Occupational CRD 25 millions

Chronic rhinosinusitis 50 millions

Post-infectious CRD No data

Lung cancer and neoplasms of the respiratory organs

Sequellae of pulmonary embolism No data

Cor pulmonale No data

Sleep apnea syndrome 100 millions

Lung fibrosis No data

TOTAL: > ONE BILLION

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

3- Modified TOR

4- Preparation of the Launch

5- "GARD manual"

Geneva« pre-GARD »WHO meeting

GARDaccepted by WHO

1st GARDassembly

1st GARD/WHOmeeting

GARDmeeting

GARDLaunch

06-04 09-04 01-05 05-05 09-05 28-03-06

GARD GARD manualmanual

Geneva« pre-GARD »WHO meeting

GARDaccepted by WHO

1st GARDassembly

1st GARD/WHOmeeting

GARDmeeting

GARDLaunch

06-04 09-04 01-05 05-05 09-05 28-03-06

GARD GARD manualmanual

GARD source document

Fact sheetsPress release

Geneva« pre-GARD »WHO meeting

GARDaccepted by WHO

1st GARDassembly

1st GARD/WHOmeeting

GARDmeeting

GARDLaunch

06-04 09-04 01-05 05-05 09-05 28-03-06

GARD GARD manualmanual

GARD source document

Public Healthguide

Pocket guide

ReviewPublished by NGOs

Launch at ERS

Steering committee report1- Consequences for GARD of the publication

of the WHO Chronic Disease report

2- GARD members

3- Modified TOR

4- Preparation of the Launch

5- "GARD manual"

6- Dissemination of GARD to countries

Activities within countriesActivities within countries• ChinaChina: launch, Chinese Medical Association: launch, Chinese Medical Association

• BrazilBrazil: Minister of Health (PAHO): Minister of Health (PAHO)

• PolandPoland: Minister of Health: Minister of Health

• IndiaIndia: President: President

• Japan, Korea..Japan, Korea..: National coordination: National coordination

• Cape Verde, Russia, TunisiaCape Verde, Russia, Tunisia: Pilot studies: Pilot studies